Cost, regulatory hurdles can make drug discovery a difficult investment

06/8/2010 | Boston Globe (tiered subscription model), The

Taking a new drug from the lab to the market in the U.S. can cost more than $1 billion and take 10 or more years. "Society would benefit from faster, less expensive access to important new drugs, especially for devastating diseases with no good current therapies," biotech entrepreneur Christoph Westphal writes. Accelerating clinical trial and regulatory time frames, increasing public funding, and outsourcing costly, labor-intensive processes to India and China could speed up the process, Westphal says.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ